Med Clin (Barc). 2005 Feb 19;124(6):229-36.

[The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases].

[Article in Spanish]

Ruiz Hernández G, Romero de Avila Y Avalos C, Carreras Delgado JL.

Source

Instituto PET Focuscan, Madrid, Spain. grh1970@hotmail.com

Abstract

Positron emission tomography (PET) has the ability to detect cancer based on molecular and biochemical processes within the tumor tissues. The most widely used radiotracer in oncology at this time is the glucose analogue 18F-fluoro-2-deoxy-D-glucose (18F-FDG). Like glucose, 18F-FDG is transported into cells by a glucose transporter protein and rapidly converted into 18F-FDG-6-phosphate. PET imaging with 18F-FDG is able to diagnose, stage, and restage many cancers with accuracies ranging from 80% to 90%. Responses to therapy can be identified earlier and with greater accuracy than is possible with anatomic imaging modalities. The prognostic information available through 18F-FDG PET is superior to that of conventional imaging for many cancers. The aim of this review article is to show the most promising clinical indications for the use of PET in oncology.

PMID:: 15737307; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review [Fluorine-18-2-deoxy-2-fluoro-D-glucose positron emission tomography in colorectal cancer]. [Sheng Wu Yi Xue Gong Cheng Xue...]
Review [Fluorine-18-2-deoxy-2-fluoro-D-glucose positron emission tomography in colorectal cancer].
Tang G, Kuang A. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005 Feb; 22(1):193-6, 201.
[Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives]. [Bull Cancer. 2005]
[Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P, Brusco S, Corone C, Devillers A, Foehrenbach H, Lumbroso JD, Maszelin P, Montravers F, Moretti JL, Rain JD, et al. Bull Cancer. 2005 Jul; 92(7):723-32.
Review Positron emission tomography: clinical applications in oncology. Part 1. [Expert Rev Anticancer Ther. 2005]
Review Positron emission tomography: clinical applications in oncology. Part 1.
Kumar R, Nadig MR, Chauhan A. Expert Rev Anticancer Ther. 2005 Dec; 5(6):1079-94.
Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report. [Ann Nucl Med. 2008]
Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
Terauchi T, Murano T, Daisaki H, Kanou D, Shoda H, Kakinuma R, Hamashima C, Moriyama N, Kakizoe T. Ann Nucl Med. 2008 Jun; 22(5):379-85. Epub 2008 Jul 4.
Review From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology. [Ann Nucl Med. 2001]
Review From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.
Kubota K. Ann Nucl Med. 2001 Dec; 15(6):471-86.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG...
[The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases].
Med Clin (Barc). 2005 Feb 19 ;124(6):229-36.

PubMed
The economic consequences of medical injuries. Implications for a no-fault insur...
The economic consequences of medical injuries. Implications for a no-fault insurance plan.
JAMA. 1992 May 13 ;267(18):2487-92.

PubMed
Correlation of hallux valgus surgical outcome with AOFAS forefoot score and radi...
Correlation of hallux valgus surgical outcome with AOFAS forefoot score and radiological parameters.
Foot Ankle Int. 2005 Feb ;26(2):122-7.

PubMed
Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhance...
Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
Virol J. 2005 Feb 28 ;2:17.

PubMed
The effect of zidovudine on patient subgroups.
The effect of zidovudine on patient subgroups.
JAMA. 1992 May 13 ;267(18):2472-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: